General Information of Drug (ID: DMOSRFZ)

Drug Name
OC-10X Drug Info
Synonyms AMD therapy, OcuCure
Indication
Disease Entry ICD 11 Status REF
Macular degeneration 9B78.3 Phase 1 [1]
Proliferative diabetic retinopathy 9B71.01 Phase 1 [2]
Cross-matching ID
PubChem CID
4793207
TTD Drug ID
DMOSRFZ

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tubulin receptor (TUBR) TT9K83W NOUNIPROTAC Inhibitor [3]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023889)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 ClinicalTrials.gov (NCT01869933) Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X. U.S. National Institutes of Health.